The effect of the pandemic on colorectal cancer in the United States: An increased disease burden

• DOI: 10.1016/j.soi.2024.100014
• Publication Date: 2024-02-09T17:49:44Z
• Authors: Tommaso Violante; Davide Ferrari; Courtney N. Day; Kellie L. Mathis; Eric J. Dozois; David W. Larson
• Keywords: Pandemic

BackgroundThe COVID-19 pandemic posed an unprecedented global threat to healthcare systems, causing delays in colorectal cancer (CRC) diagnoses. This study aims assess the impact of on presentation stages U.S.MethodsData from national database (2015-2020) were analyzed, categorizing patients into pre-COVID (2015-2019) and COVID (2020) groups for evaluation.ResultsIn group, with colon had a notably higher prevalence Clinical stage IV disease at diagnosis, accompanied by increased incidence metastatic (Clinical C, 12.9% vs. 4.5%, p < 0.001). Similar trends observed rectal 2.2% 0.8%, Black patients, those specific insurance status (Medicaid or not insured private insurance), cohort significantly associated worse clinical both multivariable analysis.ConclusionThe has led notable surge advanced-stage diagnoses, ongoing repercussions anticipated. Colorectal surgeons should devise strategies address this issue establish preparedness measures future crises.